Allurion Technologies Inc (ALUR)
1.88
+0.02
(+1.08%)
USD |
NYSE |
May 17, 16:00
1.90
+0.02
(+1.06%)
After-Hours: 20:00
Allurion Technologies SG&A Expense (Quarterly): 12.53M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 12.53M |
December 31, 2023 | 26.10M |
September 30, 2023 | 32.93M |
June 30, 2023 | 16.68M |
March 31, 2023 | 17.17M |
Date | Value |
---|---|
December 31, 2022 | 19.66M |
September 30, 2022 | 19.51M |
June 30, 2022 | 13.95M |
March 31, 2022 | 12.65M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
12.53M
Minimum
Mar 2024
32.93M
Maximum
Sep 2023
19.02M
Average
17.17M
Median
Mar 2023
SG&A Expense (Quarterly) Benchmarks
Outset Medical Inc | 32.49M |
Paragon 28 Inc | 54.22M |
Perspective Therapeutics Inc | 5.878M |
Xtant Medical Holdings Inc | 20.24M |
Asensus Surgical Inc | 8.016M |